Molecular Diagnostics Market DNA Probes and Biochips New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Cytograft Tissue Engineering, Inc. - Product Pipeline Analysis, 2014 Update

Cytograft Tissue Engineering, Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • by Global Data
  • June 2014
  • 26 pages

Summary Cytograft Tissue Engineering, Inc. (CTE) is a genetic engineering company. The company develops cell-based therapies to repair and rebuild diseased tissues and organs. It has developed a regenerative medicine platform, Tissue Engineering by Self-Assembly, or TESA. The company's products include ...

Industries: Biological Therapy | Countries: United States

Aastrom Biosciences, Inc. (Symbol:ASTM) SWOT Analysis, Strategy, Revenues and Profits

Aastrom Biosciences, Inc. (Symbol:ASTM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • June 2014
  • 137 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Aastrom Biosciences, Inc. SWOT Analysis report provides you a strategic ...

Industries: Biological Therapy | Countries: United States

Induced Pluripotent Stem Cells : Global Markets

Induced Pluripotent Stem Cells : Global Markets

  • $ 6 650
  • Industry report
  • by BCC Research
  • June 2014
  • 115 pages

This BCC Research report provides detailed market and industry analyses to help readers quantify and qualify the global market for induced pluripotent stem cells (iPSCs). Important trends of the field and market segments are identified, and market sizes and sales forecasts by segmented markets are provided ...

Industries: Biological Therapy | Countries: World, United States

ReGenX Biosciences, LLC SWOT Analysis, Strategy, Revenues and Profits

ReGenX Biosciences, LLC SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • June 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Biological Therapy | Countries: United States

Pathfinder Cell Therapy, Inc. (PFND) - Financial and Strategic SWOT Analysis Review

Pathfinder Cell Therapy, Inc. (PFND) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • June 2014
  • 25 pages

Summary Pathfinder Cell Therapy, Inc. (Pathfinder Cell Therapy) is a regenerative medicine company. The company operates in segments such as adult and pediatric market. It is a development stage regenerative medicine company which develops novel cell-based and related therapies for the treatment of organ-specific ...

Industries: Biological Therapy | Countries: United States

BioTime, Inc. (BTX) - Financial and Strategic SWOT Analysis Review

BioTime, Inc. (BTX) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • by Global Data
  • June 2014
  • 55 pages

BioTime, Inc. (BTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the ...

Industries: Biological Therapy | Countries: United States

Physician Views: Are neurologists ready to embrace gene therapy?

Physician Views: Are neurologists ready to embrace gene therapy?

  • $ 645
  • Industry report
  • by Firstword Pharma
  • June 2014

Description As recently noted by Forbes, the biotech bull market of 2013 has helped to revive an approach to drug development that had become largely abandoned and pursued by only a few devoted believers. Between the beginning of last year and early April 2014, however, 11 different companies specialising ...

Industries: Biological Therapy | Countries: United States

Herceptin-Drug Insights,2014

Herceptin-Drug Insights,2014

  • $ 1 000
  • Industry report
  • by Delve Insight
  • June 2014

DelveInsight's pharmaceuticals report, “Herceptin - Drug Insights, 2014” provides Herceptin marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, patent details, route of ...

Industries: Biological Therapy | Countries: United States

Procrit-Drug Insights,2014

Procrit-Drug Insights,2014

  • $ 1 000
  • Industry report
  • by Delve Insight
  • June 2014

DelveInsight's pharmaceuticals report, “Procrit - Drug Insights, 2014” provides Procrit marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, patent details, route of synthesis, ...

Industries: Biological Therapy | Countries: United States

Rituxan-Drug Insights,2014

Rituxan-Drug Insights,2014

  • $ 1 000
  • Industry report
  • by Delve Insight
  • June 2014

DelveInsight's pharmaceuticals report, “Rituxan - Drug Insights, 2014” provides Rituxan marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, patent details, route of synthesis, ...

Industries: Biological Therapy | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.